M&A Deal Summary |
|
---|---|
Date | 2010-01-04 |
Target | BioForm Medical |
Sector | Medical Products |
Buyer(s) | Merz Pharma KGaA |
Sellers(s) | EW Healthcare Partners |
Deal Type | Add-on Acquisition |
Deal Value | 253M USD |
Advisor(s) | J.P. Morgan Securities (Financial) Dewey & LeBoeuf LLP Ropes & Gray (Legal) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Sector | Life Science |
Revenue | 980M USD (2012) |
Merz Pharma GmbH & Co. KGaA combines the activities of its three subsidiaries, namely Merz Pharmaceuticals, Merz Consumer Care, and Merz Dental.
DEAL STATS | # |
---|---|
Overall | 1 of 6 |
Sector (Medical Products) | 1 of 2 |
Type (Add-on Acquisition) | 1 of 5 |
State (California) | 1 of 2 |
Country (United States) | 1 of 4 |
Year (2010) | 1 of 1 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2013-07-19 |
Lasya - Intellectual Property Assets
Carrboro, North Carolina, United States Lasya, Inc. - Intellectual Property Assets includes both U.S. and international patent filings of deoxyArbutin. |
Buy | - |
Category | Growth Capital Firm |
---|---|
Founded | 1985 |
PE ASSETS | 3.0B USD |
Size | Large |
Type | Sector Focused |
Essex Woodlands Health Ventures is a growth equity and venture capital specialist investment firm focused on opportunities across the healthcare sector. Specific areas of interest include biotechnology, pharmaceuticals, medical devices, and healthcare services/IT. Historically, Essex invested primarily in early and later-stage situations; however, today the firm also makes growth capital investments between $20 - $60 million in companies valued between $50 - $250 million, as well as private investments in public entities (PIPEs). Essex Woodlands was formed in 1985 and offices in Palo Alto, California; New York City; Houston, Texas; Shanghai and London.
DEAL STATS | # |
---|---|
Overall | 16 of 53 |
Sector (Medical Products) | 7 of 24 |
Type (Add-on Acquisition) | 9 of 34 |
State (California) | 6 of 17 |
Country (United States) | 14 of 46 |
Year (2010) | 1 of 7 |
Size (of disclosed) | 10 of 22 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2009-12-15 |
Molecular Partners
Schlieren, Switzerland Molecular Partners is a clinical-stage biotech company developing DARP in therapeutics, a new class of custom-built protein drugs designed to address challenges current modalities cannot. Molecular Partners was founded in 2004 and is headquartered in Schlieren, Switzerland. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2010-01-06 |
InSound Medical
Newark, California, United States InSound Medical is a developer and manufacturer of hearing devices. |
Sell | $75M |